相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer
Allison W. Kurian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer
Allison W. Kurian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making
Neal Bhutiani et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2018)
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
David J. Press et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Low utility of Oncotype DX® in the clinic
Luisel J. Ricks-Santi et al.
CANCER MEDICINE (2017)
Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study
Prema P. Peethambaram et al.
NPJ BREAST CANCER (2017)
21-Gene recurrence score decreases receipt of chemotherapy in ER plus early-stage breast cancer: an analysis of the NCDB 2010-2013
Benjamin M. Parsons et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Underutilization of gene expression profiling for early-stage breast cancer in California
Rosemary D. Cress et al.
CANCER CAUSES & CONTROL (2016)
21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile
Jagar Jasem et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer
Megan C. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Lyndsay N. Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Comparison of SEER Treatment Data With Medicare Claims
Anne-Michelle Noone et al.
MEDICAL CARE (2016)
Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study
Valentina I. Petkov et al.
NPJ BREAST CANCER (2016)
Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
Lindsey Enewold et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009
Michaela A. Dinan et al.
JAMA ONCOLOGY (2015)
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis
Josh J. Carlson et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer
Michael J. Hassett et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S. Albain et al.
LANCET ONCOLOGY (2010)
Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay
Julia R. Trosman et al.
JOURNAL OF ONCOLOGY PRACTICE (2010)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
